JANX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.40%

Insider Buying (Last 12 Months): $58,688,642.98

Insider Selling (Last 12 Months): $183,538,665.79

Janux Therapeutics Insider Trading History Chart

Janux Therapeutics Share Price & Price History

^$53.99

▼ -1.96 (-3.50%)

As of 10/31/2024 01:00 AM ET

Days: 30 | 90 | 365

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Janux Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/28/2024	David Alan Campbell	CEO	Sell	25,000	$53.54	$1,338,500.00	282,054
10/18/2024	Ra Capital Management, L.P.	Director	Buy	1,200,000	$44.75	$53,700,000.00	9,317,246
10/17/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	1,843	$50.02	$92,186.86	6,371
9/30/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	958	$46.24	$44,297.92	6,887
9/27/2024	Andrew Hollman Meyer	Insider	Sell	50,000	$45.96	$2,298,000.00	67,592
9/27/2024	David Alan Campbell	CEO	Sell	25,000	$46.31	$1,157,750.00	307,054
9/27/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	49,231	$46.45	$2,286,779.95	6,926
9/12/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	158,031	$47.00	$7,427,457.00	2,959,175
9/9/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	2,182	$42.33	$92,364.06	7,000
9/6/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	108,365	$42.00	$4,551,330.00	3,162,851
6/3/2024	Jay Lichter	Director	Sell	1,500,000	$54.75	$82,125,000.00	633,673
6/3/2024	Tighe Reardon	CFO	Sell	822,721	$54.75	$45,043,974.75	633,673
6/3/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	677,279	$54.75	$37,081,025.25	3,271,216
11/13/2023	Ventures Xi L.P. Avalon	Major Shareholder	Buy	849,854	$5.87	$4,988,642.98	849,854
7/19/2023	Ra Capital Management, L.P.	Director	Buy	495,008	$12.46	$6,167,799.68	8,117,246

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Janux Therapeutics (NASDAQ:JANX)

75.39% of Janux Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Janux Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/29/2024	Chicago Partners Investment Group LLC	5,251	$0.24M	0.0%	N/A	0.010%
10/25/2024	China Universal Asset Management Co. Ltd.	10,033	$0.46M	0.1%	+64.7%	0.019%
10/24/2024	Nisa Investment Advisors LLC	20,343	$0.92M	0.0%	+639.5%	0.039%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	1,887	$87K	0.0%	+21.9%	0.004%
10/19/2024	Allspring Global Investments Holdings LLC	5,851	$0.27M	0.0%	-6.9%	0.011%
10/10/2024	Exchange Traded Concepts LLC	3,357	$0.15M	0.0%	-41.7%	0.006%
10/3/2024	SG Americas Securities LLC	5,738	$0.26M	0.0%	-83.4%	0.011%
8/19/2024	Point72 Asset Management L.P.	136,430	$5.72M	0.0%	N/A	0.263%
8/15/2024	Blue Owl Capital Holdings LP	40,000	$1.68M	0.5%	N/A	0.077%
8/15/2024	The Manufacturers Life Insurance Company	24,048	$1.01M	0.0%	+234.7%	0.046%
8/15/2024	AQR Capital Management LLC	5,125	$0.22M	0.0%	N/A	0.010%
8/14/2024	Squarepoint Ops LLC	32,862	$1.38M	0.0%	-23.8%	0.063%
8/14/2024	Samlyn Capital LLC	324,703	$13.60M	0.2%	+9.6%	0.626%
8/14/2024	Logos Global Management LP	750,000	$31.42M	2.5%	+400.0%	1.446%
8/14/2024	HighVista Strategies LLC	23,332	$0.98M	0.4%	N/A	0.045%
8/14/2024	ProShare Advisors LLC	5,518	$0.23M	0.0%	-17.1%	0.011%
8/14/2024	Profund Advisors LLC	14,274	$0.60M	0.0%	N/A	0.028%
8/13/2024	Ensign Peak Advisors Inc	133,000	$5.57M	0.0%	N/A	0.257%
8/12/2024	Amalgamated Bank	970	$41K	0.0%	+61.1%	0.002%
8/9/2024	Dimensional Fund Advisors LP	24,019	$1.01M	0.0%	+54.0%	0.046%
8/9/2024	Plato Investment Management Ltd	999	$42K	0.0%	N/A	0.002%
8/8/2024	American Century Companies Inc.	5,627	$0.24M	0.0%	-79.2%	0.011%
8/8/2024	State of New Jersey Common Pension Fund D	7,598	$0.32M	0.0%	N/A	0.015%
8/6/2024	Quest Partners LLC	5,795	$0.24M	0.0%	+307.2%	0.011%
8/6/2024	Candriam S.C.A.	112,004	$4.69M	0.0%	+40.0%	0.216%
8/5/2024	Arizona State Retirement System	5,784	$0.24M	0.0%	N/A	0.011%
8/5/2024	Victory Capital Management Inc.	12,220	$0.51M	0.0%	N/A	0.024%
8/5/2024	Ovata Capital Management Ltd	20,000	$0.84M	0.5%	-50.0%	0.039%
8/3/2024	TD Asset Management Inc	19,800	$0.83M	0.0%	N/A	0.038%
8/1/2024	Rhumbline Advisers	38,008	$1.59M	0.0%	+41.2%	0.073%
7/29/2024	Principal Financial Group Inc.	5,647	$0.24M	0.0%	N/A	0.011%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	3,609	$0.15M	0.0%	N/A	0.007%
7/26/2024	Summit Securities Group LLC	700	$29K	0.0%	N/A	0.001%
7/26/2024	Bank of New York Mellon Corp	115,027	$4.82M	0.0%	+136.3%	0.222%
7/12/2024	SG Americas Securities LLC	34,664	$1.45M	0.0%	N/A	0.067%
7/5/2024	DNB Asset Management AS	5,273	$0.22M	0.0%	N/A	0.010%
5/20/2024	Virtu Financial LLC	16,183	$0.61M	0.0%	N/A	0.031%
5/17/2024	Artal Group S.A.	50,000	$1.88M	0.0%	N/A	0.096%
5/16/2024	California State Teachers Retirement System	16,263	$0.61M	0.0%	-5.4%	0.031%
5/16/2024	Janus Henderson Group PLC	1,965,546	$73.96M	0.0%	+1.8%	3.791%
5/16/2024	BVF Inc. IL	2,919,818	$109.93M	3.0%	-36.2%	5.631%
5/15/2024	Price T Rowe Associates Inc. MD	19,596	$0.74M	0.0%	N/A	0.038%
5/15/2024	Altitude Crest Partners Inc.	193,300	$7.28M	3.1%	N/A	0.373%
5/14/2024	StemPoint Capital LP	121,642	$4.58M	1.2%	N/A	0.235%
5/10/2024	Vanguard Group Inc.	1,357,960	$51.13M	0.0%	+38.6%	2.619%
5/9/2024	Lord Abbett & CO. LLC	542,373	$20.42M	0.1%	N/A	1.046%
5/8/2024	ProShare Advisors LLC	6,655	$0.25M	0.0%	N/A	0.013%
5/4/2024	Lester Murray Antman dba SimplyRich	7,964	$0.30M	0.1%	N/A	0.015%
5/1/2024	Capstone Investment Advisors LLC	52,300	$1.97M	0.0%	N/A	0.101%
4/30/2024	Allspring Global Investments Holdings LLC	6,349	$0.24M	0.0%	-75.8%	0.012%
4/29/2024	China Universal Asset Management Co. Ltd.	9,743	$0.37M	0.0%	+82.4%	0.019%
4/18/2024	Allspring Global Investments Holdings LLC	6,349	$0.24M	0.0%	-75.8%	0.012%
2/8/2024	Janney Montgomery Scott LLC	51,548	$0.55M	0.0%	N/A	0.112%
2/6/2024	Swiss National Bank	31,800	$0.34M	0.0%	+39.5%	0.069%
1/26/2024	Cerity Partners LLC	60,933	$0.65M	0.0%	N/A	0.132%
1/25/2024	Allspring Global Investments Holdings LLC	26,264	$0.28M	0.0%	+2,166.1%	0.057%
1/25/2024	Nisa Investment Advisors LLC	2,710	$29K	0.0%	+10,740.0%	0.006%
1/24/2024	China Universal Asset Management Co. Ltd.	5,343	$57K	0.0%	N/A	0.012%
1/12/2024	SG Americas Securities LLC	9,345	$100K	0.0%	N/A	0.020%
1/5/2024	Exchange Traded Concepts LLC	14,204	$0.15M	0.0%	+34.0%	0.031%
11/15/2023	RA Capital Management L.P.	9,165,652	$92.39M	1.8%	+5.7%	19.852%
11/15/2023	Adage Capital Partners GP L.L.C.	1,150,000	$11.59M	0.0%	+27.8%	2.491%
11/14/2023	Corton Capital Inc.	11,061	$0.11M	0.1%	N/A	0.024%
11/14/2023	Old Well Partners LLC	10,300	$0.10M	0.1%	N/A	0.022%
11/13/2023	FMR LLC	6,351,322	$64.02M	0.0%	+25.5%	13.756%
11/7/2023	Barclays PLC	17,922	$0.18M	0.0%	+227.1%	0.039%
9/21/2023	Barclays PLC	5,479	$65K	0.0%	-38.5%	0.012%
8/15/2023	BVF Inc. IL	4,106,945	$48.75M	1.4%	+159.0%	8.901%
8/14/2023	UniSuper Management Pty Ltd	138,888	$1.65M	0.0%	N/A	0.301%
7/20/2023	Exchange Traded Concepts LLC	10,010	$0.12M	0.0%	N/A	0.024%
5/16/2023	BVF Inc. IL	1,585,677	$19.19M	0.7%	+7.8%	3.790%
5/15/2023	EcoR1 Capital LLC	3,838,486	$46.45M	1.5%	+170.1%	9.176%
5/11/2023	FMR LLC	5,140,644	$62.20M	0.0%	-8.3%	12.289%
2/14/2023	Parkwood LLC	21,469	$0.28M	0.0%	-35.6%	0.052%
2/2/2023	SG Americas Securities LLC	7,902	$0.10M	0.0%	N/A	0.019%
11/8/2022	New York State Common Retirement Fund	13,259	$0.18M	0.0%	+65.5%	0.032%
8/16/2022	Woodline Partners LP	286,383	$3.50M	0.1%	+2.9%	0.687%
8/16/2022	Parkwood LLC	33,750	$34K	0.1%	+19.4%	0.081%
8/12/2022	FMR LLC	5,825,704	$71.13M	0.0%	+2.6%	13.984%
8/3/2022	DekaBank Deutsche Girozentrale	49,500	$0.57M	0.0%	N/A	0.119%
6/30/2022	Amalgamated Bank	1,928	$28K	0.0%	N/A	0.005%
5/5/2022	New York State Common Retirement Fund	15,521	$0.22M	0.0%	+63.0%	0.037%
2/19/2022	Woodline Partners LP	278,275	$5.49M	0.1%	-7.3%	0.669%
2/14/2022	Citadel Advisors LLC	1,853,432	$36.57M	0.0%	-0.3%	4.454%
2/11/2022	Parkwood LLC	32,128	$0.63M	0.1%	+54.6%	0.077%
2/8/2022	Northern Trust Corp	115,495	$2.28M	0.0%	-1.3%	0.278%
2/2/2022	New York State Common Retirement Fund	9,521	$0.19M	0.0%	+314.0%	0.023%
2/2/2022	DekaBank Deutsche Girozentrale	45,000	$0.89M	0.0%	N/A	0.108%
1/28/2022	Allspring Global Investments Holdings LLC	5,357	$0.11M	0.0%	N/A	0.013%
11/16/2021	Janus Henderson Group PLC	2,416,404	$51.38M	0.0%	-9.4%	5.807%
11/16/2021	Metropolitan Life Insurance Co NY	4,011	$87K	0.0%	N/A	0.010%
11/16/2021	BVF Inc. IL	1,017,314	$22.01M	0.9%	-13.5%	2.445%
11/16/2021	Citadel Advisors LLC	1,859,246	$39.64M	0.0%	-1.5%	4.468%
11/12/2021	Geode Capital Management LLC	211,880	$4.58M	0.0%	+862.3%	0.509%
11/10/2021	Citigroup Inc.	1,755	$38K	0.0%	-98.0%	0.004%
11/9/2021	BlackRock Inc.	801,778	$17.34M	0.0%	+629.2%	1.927%
11/4/2021	Deutsche Bank AG	8,185	$0.18M	0.0%	N/A	0.020%
11/2/2021	New York State Common Retirement Fund	2,300	$50K	0.0%	N/A	0.006%
11/1/2021	SG Americas Securities LLC	65,414	$1.42M	0.0%	N/A	0.157%
10/29/2021	Janney Montgomery Scott LLC	40,860	$0.88M	0.0%	N/A	0.098%

Data available starting January 2016

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Today's Range

Now: $53.99

$53.44

$55.25

50 Day Range

MA: $47.92

$41.26

$55.95

52 Week Range

Now: $53.99

$5.65

$65.60

Volume

604,782 shs

Average Volume

712,996 shs

Market Capitalization

$2.82 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.54

Who are the company insiders with the largest holdings of Janux Therapeutics?: Janux Therapeutics' top insider investors include:
Ra Capital Management, LP (Director)
Ventures Xi LP Avalon (Major Shareholder)
Jay Lichter (Director)
Tighe Reardon (CFO)
David Alan Campbell (CEO)
Andrew Hollman Meyer (Insider)
Learn More about top insider investors at Janux Therapeutics.
Who are the major institutional investors of Janux Therapeutics?: Janux Therapeutics' top institutional shareholders include:
Nisa Investment Advisors LLC — 0.04%
China Universal Asset Management Co. Ltd. — 0.02%
Allspring Global Investments Holdings LLC — 0.01%
SG Americas Securities LLC — 0.01%
Chicago Partners Investment Group LLC — 0.01%
Exchange Traded Concepts LLC — 0.01%
Learn More about top institutional investors of Janux Therapeutics stock.
Which institutional investors are selling Janux Therapeutics stock?: In the last quarter, JANX stock was sold by these institutional investors:
SG Americas Securities LLC
Exchange Traded Concepts LLC
Belvedere Trading LLC
Allspring Global Investments Holdings LLC
Within the last year, company insiders that have sold Janux Therapeutics company stock include:
Ra Capital Management, LP (Director)
Ventures Xi LP Avalon (Major Shareholder)
Jay Lichter (Director)
Tighe Reardon (CFO)
David Alan Campbell (CEO)
Learn More investors selling Janux Therapeutics stock.
Which institutional investors are buying Janux Therapeutics stock?: In the last quarter, JANX stock was acquired by institutional investors including:
Nisa Investment Advisors LLC
Chicago Partners Investment Group LLC
China Universal Asset Management Co. Ltd.
Mirae Asset Global Investments Co. Ltd.
During the last year, these company insiders have bought Janux Therapeutics stock:
Ra Capital Management, LP (Director)
Ventures Xi LP Avalon (Major Shareholder)
Learn More investors buying Janux Therapeutics stock.